522 related articles for article (PubMed ID: 27424773)
1. Cutaneous leishmaniasis: immune responses in protection and pathogenesis.
Scott P; Novais FO
Nat Rev Immunol; 2016 Sep; 16(9):581-92. PubMed ID: 27424773
[TBL] [Abstract][Full Text] [Related]
2. [Immunopathology of American tegumentary leishmaniasis].
Castés M; Tapia FJ
Acta Cient Venez; 1998; 49(1):42-56. PubMed ID: 10205916
[TBL] [Abstract][Full Text] [Related]
3. Review on the Role of Host Immune Response in Protection and Immunopathogenesis during Cutaneous Leishmaniasis Infection.
Dubie T; Mohammed Y
J Immunol Res; 2020; 2020():2496713. PubMed ID: 32656269
[TBL] [Abstract][Full Text] [Related]
4. Regulator and effector functions of T-cell subsets in human Leishmania infections.
Kemp M
APMIS Suppl; 1997; 68():1-33. PubMed ID: 9063493
[TBL] [Abstract][Full Text] [Related]
5. Early CD44(hi)CD4+ and CD44(hi)CD8+ T cell numbers and the absence of mannose-rich glycoconjugates determine the protective outcome of anti-leishmanial immunity.
Kedzierski L; Curtis JM; Kedzierska K
Parasitology; 2009 Jul; 136(8):833-40. PubMed ID: 19490731
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells are preferentially activated during primary low dose leishmania major infection but are completely dispensable during secondary anti-Leishmania immunity.
Okwor IB; Jia P; Mou Z; Onyilagha C; Uzonna JE
PLoS Negl Trop Dis; 2014; 8(11):e3300. PubMed ID: 25412267
[TBL] [Abstract][Full Text] [Related]
7. CD8 cytotoxic T cells in cutaneous leishmaniasis.
Ruiz JH; Becker I
Parasite Immunol; 2007 Dec; 29(12):671-8. PubMed ID: 18042173
[TBL] [Abstract][Full Text] [Related]
8. CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly.
Novais FO; Scott P
Semin Immunopathol; 2015 May; 37(3):251-9. PubMed ID: 25800274
[TBL] [Abstract][Full Text] [Related]
9. CD4+ type 1 and CD8+ type 2 T cell subsets in human leishmaniasis have distinct T cell receptor repertoires.
Uyemura K; Pirmez C; Sieling PA; Kiene K; Paes-Oliveira M; Modlin RL
J Immunol; 1993 Dec; 151(12):7095-104. PubMed ID: 7903101
[TBL] [Abstract][Full Text] [Related]
10. Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection.
Peters NC; Pagán AJ; Lawyer PG; Hand TW; Henrique Roma E; Stamper LW; Romano A; Sacks DL
PLoS Pathog; 2014 Dec; 10(12):e1004538. PubMed ID: 25473946
[TBL] [Abstract][Full Text] [Related]
11. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
12. A Historic Review of the Role of CD4+ T-Cell Subsets in Development of the Immune Responses against Cutaneous and Visceral Leishmaniases.
Alimohmmadian MH; Ajdary S; Bahrami F
Iran Biomed J; 2022 Mar; 26(2):99-109. PubMed ID: 35090305
[TBL] [Abstract][Full Text] [Related]
13. Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells.
Herath S; Kropf P; Müller I
Parasite Immunol; 2003; 25(11-12):559-67. PubMed ID: 15053777
[TBL] [Abstract][Full Text] [Related]
14. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
Iborra S; Soto M; Carrión J; Alonso C; Requena JM
Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
[TBL] [Abstract][Full Text] [Related]
15. CD4+, CD8+ and CD4- CD8- T cell-subsets can confer protection against Leishmania m. mexicana infection.
Lezama-Dávila CM; Gallagher G
Mem Inst Oswaldo Cruz; 1995; 90(1):51-8. PubMed ID: 8524085
[TBL] [Abstract][Full Text] [Related]
16. Detection of early apoptosis and cell death in T CD4+ and CD8+ cells from lesions of patients with localized cutaneous leishmaniasis.
Bertho AL; Santiago MA; Da-Cruz AM; Coutinho SG
Braz J Med Biol Res; 2000 Mar; 33(3):317-25. PubMed ID: 10719384
[TBL] [Abstract][Full Text] [Related]
17. Cellular immune responses to Leishmania braziliensis in patients with AIDS-associated American cutaneous leishmaniasis.
Da-Cruz AM; Mattos M; Oliveira-Neto MP; Coutinho Z; Machado ES; Coutinho SG
Trans R Soc Trop Med Hyg; 2000; 94(5):569-71. PubMed ID: 11132391
[No Abstract] [Full Text] [Related]
18. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
19. Memory T cells in cutaneous leishmaniasis.
Glennie ND; Scott P
Cell Immunol; 2016 Nov; 309():50-54. PubMed ID: 27493096
[TBL] [Abstract][Full Text] [Related]
20. Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection.
Satoskar AR; Stamm LM; Zhang X; Satoskar AA; Okano M; Terhorst C; David JR; Wang B
J Immunol; 1999 Jun; 162(11):6747-54. PubMed ID: 10352294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
